Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Prognostic Significance of Reduced BCAS4 expression in Bone Marrow Cells of Patients with Myelodysplastic Syndromes

Masayuki Shiseki, MD PhD, Mayuko Ishii, Mari Ohwashi, Kentaro Yoshinaga, MD PhD, Naoki Mori, MD PhD, Junji Tanaka, MD PhD

Blood (2019) 134 (Supplement_1): 4258.

https://doi.org/10.1182/blood-2019-124738

Published: 2019

Journal Articles

Retrospective Analysis of Treatment Outcomes for Patients with Follicular Lymphoma and Comorbidities

Aya Watanabe, Yoichi Imai, MD PhD, Kenjiro Mitsuhashi, MD PhD, Akihito Shinohara, Norina Tanaka, MD PhD, Kentaro Yoshinaga, MDPhD, Masayuki Shiseki, MD PhD, Naoki Mori, MD PhD, Junji Tanaka, MD PhD

Blood (2015) 126 (23): 5082.

https://doi.org/10.1182/blood.V126.23.5082.5082

Published: 2015

Journal Articles

Reduced PLCG1 expression Is Associated with Inferior Survival in Myelodysplastic Syndromes

Masayuki Shiseki, MD PhD, Mayuko Ishii, Mari Ohwashi, Kentaro Yoshinaga, MDPhD, Naoki Mori, MD PhD, Junji Tanaka, MD, PhD

Blood (2015) 126 (23): 1700.

https://doi.org/10.1182/blood.V126.23.1700.1700

Published: 2015

Journal Articles

Fractionated ICE with Rituximab Is Safe and Effective for Relapse/Refractory DLBCL Patients with Severe Comorbidities

Norina Tanaka, MD PhD, Yoichi Imai, MD PhD, Aya Watanabe, MD, Kenjiro Mitsuhashi, MD PhD, Kentaro Yoshinaga, MDPhD, Masayuki Shiseki, MD PhD, Naoki Mori, MD PhD, Junji Tanaka, MD, PhD

Blood (2015) 126 (23): 2713.

https://doi.org/10.1182/blood.V126.23.2713.2713

Published: 2015

Journal Articles

Prognostic Implications Of PRAME Expression Levels In Myelodysplastic Syndromes

Masayuki Shiseki, MD, PhD, Mayuko Ishii, Kenjiro Mitsuhashi, MD, Norina Tanaka, MD, Kentaro Yoshinaga, MD, PhD, Naoki Mori, MD, PhD, Junji Tanaka, MD, PhD

Blood (2013) 122 (21): 2814.

https://doi.org/10.1182/blood.V122.21.2814.2814

Published: 2013

Journal Articles

Heat Shock Protein 90 Inhibitor NVP-AUY922 Has Potent Anti-Tumor Activity With Adult T-Cell Leukemia-Lymphoma Cells

Hiroaki Taniguchi, MD, Hiroo Hasegawa, MD, PhD, Daisuke Sasaki, PhD, Koji Ando, MD, PhD, Yasushi Sawayama, MD, PhD, Yoshitaka Imaizumi, MD, PhD, Daisuke Imanishi, MD, PhD, Jun Taguchi, MD, PhD, Tomoko Hata, MD, PhD, Kunihiro Tsukasaki, MD, PhD, Katsunori Yanagihara, MD, PhD, Naoki Mori, MD, PhD, Yasushi Miyazaki, MD, PhD

Blood (2013) 122 (21): 1829.

https://doi.org/10.1182/blood.V122.21.1829.1829

Published: 2013

Journal Articles

Molecular Analyses of Deletion of the Long Arm of Chromosome 20 in Myelodysplastic Syndromes

Masayuki Shiseki, MD, Naoki Mori, MD, PhD, Michiko Okada, PhD, Toshiko Motoji, MD, PhD

Blood (2012) 120 (21): 3834.

https://doi.org/10.1182/blood.V120.21.3834.3834

Published: 2012

Journal Articles

Methylation of the RIZ1 Gene In Myelodysplastic Syndrome and Acute Myeloid Leukemia

Naoki Mori, MD, PhD, Kentaro Yoshinaga, MD, PhD, Mari Ohwashi, MHS, Toshiaki Kondoh, MD, Hanae Shimura, MD, Yan-Hua Wang, MD, PhD, Kenjiro Mitsuhashi, MD, Masayuki Shiseki, MD, PhD, Michiko Okada, PhD, Toshiko Motoji, MD, PhD

Blood (2010) 116 (21): 5112.

https://doi.org/10.1182/blood.V116.21.5112.5112

Published: 2010

Journal Articles

Overexpression of SOX5 by a Novel Chromosome Translocation Involving the IGH Locus In a Follicular Lymphoma without BCL2 Expression

Masayuki Shiseki, MD, PhD, Akihiro Masuda, MD, PhD, Yan-Hua Wang, Kentaro Yoshinaga, MD, PhD, Naoki Mori, MD, PhD, Masanao Teramura, MD, PhD, Toshiko Motoji, MD, PhD

Blood (2010) 116 (21): 4453.

https://doi.org/10.1182/blood.V116.21.4453.4453

Published: 2010

Journal Articles

Transactivation of CCL20 Gene by CD30 in Hodgkin’s Lymphoma.

Naoki Mori, MD, PhD, Taeko Okudaira, M.D., Ph.D., Kazuo Yamamoto, M.D., Ph.D., Ryouichi Horie, M.D., Ph.D., Toshiki Watanabe, M.D., Ph.D., Toshifumi Matsuyama, M.D., Ph.D.

Blood (2006) 108 (11): 2258.

https://doi.org/10.1182/blood.V108.11.2258.2258

Published: 2006

Journal Articles

The Bisphosphonate, Incadronate, Inhibits Cell Growth of HTLV-I-Infected T-Cell Lines and Primary ATL Cells by Inhibiting Mevalonate Pathway.

Chie Ishikawa, Taeko Okudaira, Mariko Tomita, MD, PhD, Naoki Mori, MD, PhD

Blood (2005) 106 (11): 4809.

https://doi.org/10.1182/blood.V106.11.4809.4809

Published: 2005

Journal Articles

Suppression of Cell Growth and Induction of Apoptosis of HTLV-I-Infected T-Cell Lines and Primary ATL Cells by Galectin-9.

Taeko Okudaira, Mariko Tomita, MD, PhD, Mitsuomi Hirashima, MD, PhD, Naoki Mori, MD, PhD

Blood (2005) 106 (11): 4810.

https://doi.org/10.1182/blood.V106.11.4810.4810

Published: 2005

NARROW

Prognostic Significance of Reduced BCAS4 expression in Bone Marrow Cells of Patients with Myelodysplastic Syndromes

Retrospective Analysis of Treatment Outcomes for Patients with Follicular Lymphoma and Comorbidities

Reduced PLCG1 expression Is Associated with Inferior Survival in Myelodysplastic Syndromes

Fractionated ICE with Rituximab Is Safe and Effective for Relapse/Refractory DLBCL Patients with Severe Comorbidities

Prognostic Implications Of PRAME Expression Levels In Myelodysplastic Syndromes

Heat Shock Protein 90 Inhibitor NVP-AUY922 Has Potent Anti-Tumor Activity With Adult T-Cell Leukemia-Lymphoma Cells

Molecular Analyses of Deletion of the Long Arm of Chromosome 20 in Myelodysplastic Syndromes

Methylation of the RIZ1 Gene In Myelodysplastic Syndrome and Acute Myeloid Leukemia

Overexpression of SOX5 by a Novel Chromosome Translocation Involving the IGH Locus In a Follicular Lymphoma without BCL2 Expression

Transactivation of CCL20 Gene by CD30 in Hodgkin’s Lymphoma.

The Bisphosphonate, Incadronate, Inhibits Cell Growth of HTLV-I-Infected T-Cell Lines and Primary ATL Cells by Inhibiting Mevalonate Pathway.

Suppression of Cell Growth and Induction of Apoptosis of HTLV-I-Infected T-Cell Lines and Primary ATL Cells by Galectin-9.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only